LEMAITRE VASCULAR, INC. (LMAT) Free cash flow 2016–2025
LEMAITRE VASCULAR, INC. (LMAT) annual free cash flow history — operating cash flow minus capital expenditures, per SEC filings.
$74.5MFY2025 · since FY2016: $14.1M → $74.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $74.5M | +100.4% |
| FY2024 | $37.2M | +26.0% |
| FY2023 | $29.5M | +33.1% |
| FY2022 | $22.1M | -26.7% |
| FY2021 | $30.2M | -5.0% |
| FY2020 | $31.8M | +205.4% |
| FY2019 | $10.4M | -36.7% |
| FY2018 | $16.5M | +0.0% |
| FY2017 | $16.5M | +17.0% |
| FY2016 | $14.1M | — |
Free cash flow = reported operating cash flow − reported capital expenditures for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice